John Desjardins
- Co-authors
- Patrick L. IversenFrank C. RichardsonRobert H. HeflichThomas J. BucciVasily N. DobrovolskyEric BrownDennis J. MeyerDavid L. Emerson
- Topics
- Pharmacogenetics and Drug Metabolism (3 papers)Drug Transport and Resistance Mechanisms (2 papers)Cancer therapeutics and mechanisms (2 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
John Desjardins
13 papers receiving 287 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 159
- Oncology 72
- Infectious Diseases 42
- Biomaterials 34
- Virology 25
Countries citing papers authored by John Desjardins
This map shows the geographic impact of John Desjardins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Desjardins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Desjardins more than expected).
Fields of papers citing papers by John Desjardins
This network shows the impact of papers produced by John Desjardins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Desjardins. The network helps show where John Desjardins may publish in the future.
Co-authorship network of co-authors of John Desjardins
This figure shows the co-authorship network connecting the top 25 collaborators of John Desjardins. A scholar is included among the top collaborators of John Desjardins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Desjardins. John Desjardins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 12 | |
| 3 | 48 | |
| 4 | 46 | |
| 5 | 15 | |
| 6 | Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan. | 51 |
| 7 | 15 | |
| 8 | 10 | |
| 9 | Enhanced delivery and effectiveness of antisense oligonucleotides when bound to intravenous perfluorocarbon-filled microbubbles: Effect of ultrasound and therapeutic implications | 5 |
| 10 | 23 | |
| 11 | 25 | |
| 12 | 3 | |
| 13 | 31 |
About John Desjardins
John Desjardins is a scholar working on Pharmacology, Pharmaceutical Science and Oncology, having authored 13 papers that have together received 304 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Virology (25 citations), Biological Psychiatry (8 citations) and Oncology (72 citations). John Desjardins has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Patrick L. Iversen, Frank C. Richardson, Robert H. Heflich, Thomas J. Bucci, Vasily N. Dobrovolsky, Eric Brown, Dennis J. Meyer, David L. Emerson, Marta Hamilton and Blake Tomkinson. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Pharmaceutical Research and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.